Physikalisch-Technische Bundesanstalt (PTB)Braunschweig
Accreditation expert: Validation and Verification (ISO/IEC 17029), Inspection (ISO /IEC 17020) and Product Certification (ISO/IEC 17065)
PTB supports Ukraine and Moldova with internal audits (IA) for their accreditation bodies to prepare for EA peer evaluations. Ukraine: remote IA of NAAU covering all schemes, Sept–Dec 2026, prior to May 2027 evaluation. Moldova: on-site IA of MOLDAC covering testing/calibration/medical labs, inspection, product and management system certi...
Submission deadline: June 04, 2026 (expired)Type: Tender
Unlock documents for free
No credit card · Instant access
Content at a glance
PTB supports Ukraine and Moldova with internal audits (IA) for their accreditation bodies to prepare for EA peer evaluations. Ukraine: remote IA of NAAU covering all schemes, Sept–Dec 2026, prior to May 2027 evaluation. Moldova: on-site IA of MOLDAC covering testing/calibration/medical labs, inspection, product and management system ce...
- Tender type:
- Tender
- Contracting authority:
- Physikalisch-Technische Bundesanstalt (PTB)
- Published:
- May 19, 2026
- Deadline:
- June 04, 2026
Tender description
PTB supports Ukraine and Moldova with internal audits (IA) for their accreditation bodies to prepare for EA peer evaluations. Ukraine: remote IA of NAAU covering all schemes, Sept–Dec 2026, prior to May 2027 evaluation. Moldova: on-site IA of MOLDAC covering testing/calibration/medical labs, inspection, product and management system certification bodies, May–Sept 2026, prior to Feb/Mar 2027 evaluation.
Further details
After registration, documents, deadlines and submission notes are available in a structured format.
- Core requirements of the tender prioritized and prepared
- Deadlines, eligibility criteria and documents in one workflow
- Guidance for structured bid preparation
- Automatically discover matching follow-up tenders
Documents and attachments
2 files recorded- Bekanntmachung
- No ID
Related tenders
4- Physikalisch-Technische Bundesanstalt (PTB)BraunschweigDeadline: Jun 04
Accreditation expert: Management systems certification (ISO 17021), Certification of persons (ISO/IEC 17024) and Inspection (ISO/IEC 17020)
Im Rahmen der internationalen Zusammenarbeit unterstützt die PTB Partnerländer bei der Entwicklung ihrer Qualitätsinfrastruktur. Für das Ukraine-Projekt 2026-2028 wird ein internes Audit (IA) der NAAU (alle Akkreditierungsschemata, remote, Sept.-Dez. 2026) vor der EA-Begutachtung im Mai 2027 durchgeführt. Für das Moldau-Projekt wird ein IA der MOLDAC (Prüf-, Kalibrier-, medizinische Labore, Inspektionsstellen, Produkt- und Managementsystemzertifizierungsstellen, vor Ort, Mai-Sept. 2026) vor der EA-Begutachtung im Feb./März 2027 durchgeführt. - European Defence AgencyRue des Drapiers, 17-23Deadline: Jul 26
Support to Defence Innovation and Operational Experimentation Activities, including BraveTech EU Testing and Evaluation Campaigns (Phase 2) - Request for information (RFI)/market survey - Information Session: 3 September 2026
EDA intends to launch a procurement procedure for a framework service contract covering operational planning, management and execution; technical evaluation support; prize-contest administration; and communication and event services, in support of EDA's defence innovation and operational experimentation activities under the Hub for European Defence Innovation (HEDI). The procurement forms part of the EUDIS BraveTech EU initiative, funded by the EU under the European Defence Fund (EDF) and implemented by EDA under indirect management. Its primary object is the BraveTech EU Testing and Evaluation Campaigns (TECS) (Phase 2), announced on 11 July 2025. Building on the Phase 1 DefTech Forges (European Commission call for tenders EC-DEFIS/2025/OP/0040), Phase 2 comprises 16 Operational Experimentation (OPEX) campaigns in which Phase 1 pre-selected companies test and refine their solutions under operational conditions. Campaigns are governed by a prize-contest mechanism under FR (EU, Euratom) 2024/2509, under which EDA's authorising officer awards prizes of up to EUR 1 000 000 per entity to the best-performing solutions. The contractor(s) shall plan, manage and execute the campaigns on EDA's behalf - including calls for host locations, coordination with host-nation authorities and site operators, logistics, spectrum and safety management, evaluation support, reporting, communication and events, and prize-contest administration - across EU Member States and EDF-associated countries over 2026–2028. The framework contract(s) may also be used to order similar services within the scope and maximum value set out in the procurement documents. The contract is not divided into lots. This notice announces EDA's intention to publish a future call for tenders, an information session for economic operators on 3 September 2026, 10:00–12:00 (CET), and the launch of a market survey (RFI). ++++++++ A. Information Session ( https://forms.office.com/Pages/ResponsePage.aspx?id=X2-UUFRBmkuNd2juNtVUZwsZ5vnJdEJAqruSaWPkOpdUN1VZRTQ2VjZPT1pZQ05QMVRUSkg5MVI4RC4u ) On 3 September 2026, 10:00–12:00 (CET), the European Defence Agency (EDA), through its Hub for European Defence Innovation (HEDI), will hold an Information Session for industry to present the BraveTech EU programme and the Phase 2 procurement approach. The session will cover the procurement strategy and the scope of the forthcoming tender — implementation plan, deliverables, contractual procedures and indicative timeline. The services to be procured cover the operational management of the Operational Experimentation (OPEX) campaigns, including calls for host locations; coordination with host-nation authorities (military or civil) and site operators; logistics and site preparation; spectrum and safety management; technical and operational evaluation support; documentation and reporting; prize-contest administration; and programme communication. The procurement seeks experienced partners to support a large-scale defence technology experimentation programme accelerating the testing, evaluation and operational transition of innovative solutions from European SMEs and start-ups, in response to capability needs identified by EU Member States and Ukraine. More information is provided in Section 2.1.4 "Additional Information" +++++++++++ B. Request for information ( https://ec.europa.eu/eusurvey/runner/Draft_EDA_Survey_on_National_Defence_Testing_Facilities ) In parallel with the Prior Information Notice, EDA is launching a Request for Information (RFI) / Market Survey directed at testing and experimentation centres, ranges, and related facilities established in EU Member States or EDF-associated countries, that may be considered as potential host locations for BraveTech EU OPEX Campaigns under Phase 2. More information is provided in Section 2.1.4 "Additional Information". 81322845-MAV+: Technical assistance for selected companies in the pharmaceutical sector in South Africa for the SAVax project
SAVax conducted a landscape assessment of South Africa's biopharmaceutical industry, covering the pharmaceutical, biotechnological, and biomanufacturing sectors as well as a call for applica-tions for companies to self-identify their technical assistance needs. The objective of this assignment is to engage a service provider to provide tailored technical assistance for the selected companies in the biopharmaceutical sector. This technical assistance aims at enhancing the capacities of companies to gain market access with their products. The goal is to equip these companies with the knowledge and skills necessary to advance their products to market access. The selected companies will receive targeted, non-financial support addressing the technical, regulatory, organizational, and strategic challenges they face in advancing biopharmaceutical products to market. Support areas may include, but are not limited to, the following: 1. Technology Platforms and Innovation Readiness o mRNA Technology Transfer Support: Assistance in understanding, adapting, or implementing mRNA-based platforms, including guidance on formulation, delivery systems, process design, cold-chain logistics, and regulatory considerations for mRNA therapeutics or vaccines. o Digitisation of cGMP Systems: Support in planning and implementing digital systems for Good Manufacturing Practice (GMP) compliance. This includes electronic batch records, quality management systems (QMS), equipment calibration tracking, and data integrity solutions aligned with international norms. 2. Regulatory and Quality Systems Strengthening o Navigating Regulatory Pathways: Tailored guidance for interacting with SAHPRA and other relevant authorities (e.g. WHO Prequalification), including dossier preparation, clinical trial applications, reliance mechanisms, and fast-track pathways. Also includes strategic regulatory planning for biosimilars and advanced therapies. o Quality Management Process Strengthening: Support in designing, upgrading, or implementing fit-for-purpose Quality Management Systems (QMS) based on ICH Q10 principles. This includes standard operating procedures (SOPs), change control, deviation management, and risk-based approaches to quality oversight. o ISO Certification Readiness: Technical support to prepare for ISO 9001, 13485 or other relevant certifications, including gap assessments, internal audits, documentation guidance, and quality culture development. o GMP Training and Compliance Advisory: Provision of technical training in GMP principles, inspection readiness, and facility hygiene requirements, adapted to different staff levels (operators, QA/QC, management). May include site-specific support for corrective/preventive actions (CAPA). 3. Intellectual Property and Commercial Strategy o Intellectual Property (IP) Strategies: Support in designing or refining IP strategies including freedom-to-operate analyses, IP landscaping, filing strategies (local and international), and licensing terms. Emphasis on protection in the context of part-nerships and technology transfer. o Optimising Commercialisation Pathways: Advisory services to develop and refine commercial strategies, including go-to-market models, pricing approaches, and health economic value propositions. May include support in understanding procurement systems (e.g. NHI, pooled African mechanisms). o Market Assessment and Market Access Support: Tailored market research to eval-uate demand, pricing, competition, and policy environments in local and regional markets. Support may include alignment with public procurement frameworks and donor-funded demand sources. 4. Organisational Resilience and Investment Readiness o Financial Restructuring and Strategy Advisory: Guidance on cost structures, business modelling, and capital allocation to improve organisational sustainability. Support may include preparing for audits, understanding grant or equity implications, or structuring financials for growth. o Managing Investor Relations: Capacity-building on investor engagement, including pitch deck refinement, term sheet review, investor reporting frameworks, and relationship management practices that align with sector expectations. o Mentorship Programmes: Pairing of companies with seasoned executives, technical experts, or entrepreneurs who can provide continuous coaching in technical, strategic, and commercial areas. Structured mentorship plans with KPIs will be encouraged. 5. Human Capital and Collaboration o Strategies for Talent Development and Retention: Development of internal work-force strategies including upskilling plans, career progression models, and organisational culture interventions to reduce talent attrition in critical areas like QC, regulatory affairs, and bioprocessing. o Managing Strategic Partnerships: Support in structuring and managing public-private partnerships, consortia, and technology transfer agreements. This includes due diligence, contractual frameworks, IP considerations, and governance models to ensure mutual value. o Facilitation of International Training Exchanges: Design and support of outbound and inbound staff exchange opportunities with regional or international centres of excellence, including identification of partner institutions, logistics coordination, and documentation of learning outcomes.- European Defence AgencyRue des Drapiers, 17-23Deadline: Jun 10
Supply of Small Arms Ammunition and Auto Canon Ammunition Internal identifier: CPoA B PRJ.CAP.1269 2026
Supply of NATO calibre Small Arms ammunition and Auto Canon ammunition, structured in 19 lots covering various NATO calibres (5.56mm×45; 7.62mm×51; 9mm×19; 12.7mm×99; and 30mm x 173) and types (inter alia Ball; Tracer; Armour Piercing; High Explosive Incendiary etc.). Each lot covers a specific calibre and type in either linked or unlinked formats, as specified hereunder. Additional Information: This procurement procedure is conducted in two stages. In the first stage, economic operators interested in the framework contract(s) are invited to submit a request to participate, drafted in one of the official languages of the European Union. In the second stage, only candidates selected following the evaluation of the requests to participate will be invited to submit a tender. Any tender submitted by a natural or legal person that has not been invited to tender will be rejected. Economic operators that possess the requisite financial capacity to perform the framework contract(s) in accordance with the applicable EU and/or national legislation, and as further specified under the Tendering Terms of the relevant Lot, may request to be invited to tender by submitting a request to participate in accordance with the following cumulative requirements: The request to participate template must be requested by email from EDA Procurement at [email protected]. The request shall clearly state in the subject the Internal identifier: CPoA B PRJ.CAP.1269 2026. The duly completed and signed request to participate must be submitted by email to EDA Procurement at [email protected] no later than 01 June 2026 at 15:00 (Brussels time). The request must be accompanied by a duly completed and signed Legal Entity Form (available at: https://commission.europa.eu/publications/business-partners-legal-entities-and-bank-accounts_en). The submission of a request to participate does not constitute a guarantee of selection. All criteria, requirements, and conditions applicable to this procurement procedure will be set out in the procurement documents made available to invited candidates as part of the invitation to tender. The Contracting Authority reserves the right to cancel the procedure at any time prior to the signature of the contract, without any obligation to compensate the candidates or tenderers.
Frequently asked questions about this tender
- How can I apply for this tender?
- Create a free account on Auftrag One. You will then see all documents, deadlines and submission notes in a structured workflow.
- What is the submission deadline?
- The submission deadline is 04. Juni 2026.
- Who is the contracting authority?
- The contracting authority is Physikalisch-Technische Bundesanstalt (PTB).
- Which documents are needed to get started?
- Typically you need the service description, proof of eligibility, deadline notes and possibly form sheets. On Auftrag One these items are displayed in prioritized order.